CONDUIT PHARMACEUTICALS INC (CDT)

Which stocks are most active on Thursday?

Let's dive into the action on the US markets on Thursday. Here are the most active stocks that are driving the market today.

Stay updated with the stocks that are on the move in today's pre-market session.

The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics Approach...

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Approval of composition of matter patent in key jurisdiction underscores the Company’s commitment to maximize future out-licensing value

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders...

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors...

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline

Conduit Pharmaceuticals announces new addition to its autoimmune pipeline, underscored by composition of matter patent filing to strengthen its competitive...

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

SAN DIEGO and LONDON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), today announced the...

Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

SAN DIEGO and LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), today announced it will...

Why Is Conduit Pharmaceuticals (CDT) Stock Up 12% Today?

Conduit Pharmaceuticals stock is up on Wednesday alongside heavy trading following an invest update on CDT shares.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Pre-market stock movers are a hot topic on Wednesday and we have all of the biggest stories traders need to know about this morning!

CDT Stock Earnings: Conduit Pharmaceuticals Reported Results for Q2 2024

Conduit Pharmaceuticals just reported results for the second quarter of 2024.

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders...

Why Is Conduit Pharmaceuticals (CDT) Stock Up 123% Today?

Conduit Pharmaceuticals stock is up on Thursday with heavy trading of CDT shares after the company announce a new license agreement.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to dive into the biggest pre-market stock movers on Thursday morning with all of the latest news this morning!

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments...